[Posterior capsule opacification, glistenings and visual outcomes: 3 years after implantation of a new hydrophobic IOL].
In: Journal francais d'ophtalmologie, Jg. 41 (2018-06-01), Heft 6, S. 513-520
academicJournal
Zugriff:
Purpose: To evaluate the visual outcomes, the incidence of glistenings and posterior capsule opacification in a series of consecutive eyes with a new blue light-filtering hydrophobic acrylic intraocular lens (IOL) SETTING: Service d'ophtalmologie, clinique Beausoleil, avenue de Lodève, Montpellier.
Design: Retrospective, cross-sectional study.
Methods: This study included a series of 66 eyes that underwent routine cataract surgery with PODEye (PhysIOL SA, Liège, Belgium) monofocal IOL implantation between May 2011 and November 2011. These eyes were compared for glistenings with patients implanted with Acrysof material IOL (Alcon, Fort Worth, USA) who had a routine postoperative examination between January 2015 and August 2015. The safety of the IOL was assessed by visual acuity outcomes, as well as rotational stability, centration and postoperative medication. The incidence and severity of glistenings were evaluated with the slit lamp. Glistenings and PCO were graded subjectively (0=absent; 1=moderate; 2=dense). Follow-up was 3 years.
Results: The mean visual acuity after PODEye implantation was 0.98±0.05 (n=50) in decimal notation at 1 year, 0.98±0.06 at 1 week, (n=66), 1.00±0.01 at 3 weeks (n=64) and 0.99±0.02 at 3 months (n=59). The IOL displayed stable positioning in all axes. Glistenings of grade 2 were absent in the G-Free/PODEye group, whereas they were significantly present in the Acrysof group. One out of 43 eyes at 3-year follow-up underwent YAG capulotomy at 37 months. Sixty-six percent of eyes had no PCO (grade 0) at 3 years.
Conclusions: The PODEye IOL was safe and stable. Glistenings grade 2 or more were not found with this blue light-filtering hydrophobic acrylic IOL. PCO occurrence was low at three years.
(Copyright © 2018 Elsevier Masson SAS. All rights reserved.)
Titel: |
[Posterior capsule opacification, glistenings and visual outcomes: 3 years after implantation of a new hydrophobic IOL].
|
---|---|
Autor/in / Beteiligte Person: | Chassain, C ; Chamard, C |
Zeitschrift: | Journal francais d'ophtalmologie, Jg. 41 (2018-06-01), Heft 6, S. 513-520 |
Veröffentlichung: | Paris, New York, Masson., 2018 |
Medientyp: | academicJournal |
ISSN: | 1773-0597 (electronic) |
DOI: | 10.1016/j.jfo.2017.11.022 |
Schlagwort: |
|
Sonstiges: |
|